![Open access](/images/ico/o.png)
![](/images/ico/ico5.png)
Author: Daly Ann K. Rettie Allan E. Fowler Douglas M. Miners John O.
Publisher: MDPI
E-ISSN: 2075-4426|8|1|1-1
ISSN: 2075-4426
Source: Journal of Personalized Medicine, Vol.8, Iss.1, 2017-12, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/o.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/o.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacology, Vol. 95, Iss. 5-6, 2015-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Inhibitory Effect of Apigenin on Losartan Metabolism and CYP2C9 Activity in vitro
Pharmacology, Vol. 98, Iss. 3-4, 2016-06 ,pp. :